Issue 21 March 2013
The HIV
Vaccine
What makes SAV001-H different from
other attempts that passed Phase 1?
Pharma
Technology Focus
IN THIS ISSUE
Antibody-drug conjugates
Crowdfunding clinical research
Continuous manufacturing
Contents
Issue #21 | March 2013
Pharma
Technology Focus